Related Experiment Videos
Bone tissue in rheumatoid arthritis (2). Pathophysiologic data, pathologic findings, and therapeutic implications
B Cortet1, R M Flipo, B Duquesnoy
1Rheumatology Department, Lille Regional Teaching Hospital, France.
Revue Du Rhumatisme (English Ed.)
|March 1, 1995
Summary
Rheumatoid arthritis causes significant bone loss, increasing fracture risk by 100%. Bone formation markers decrease while resorption markers increase, indicating a bone remodeling imbalance.
Area of Science:
- Rheumatology
- Bone Metabolism
- Osteoimmunology
Background:
- Rheumatoid arthritis (RA) is associated with bone decalcification, though the extent varies.
- RA patients exhibit a doubled fracture risk compared to the general population.
Purpose of the Study:
- To summarize current understanding of bone mass changes in rheumatoid arthritis.
- To explore the relationship between RA disease activity and bone health.
- To review factors influencing bone loss and potential therapeutic interventions.
Main Methods:
- Review of recent scientific literature on rheumatoid arthritis and bone metabolism.
- Analysis of studies correlating disease activity markers with bone mineral density.
- Evaluation of bone turnover markers (formation and resorption) in RA patients.
Main Results:
- Bone mass, particularly in the proximal femur, decreases in RA patients.
- Bone loss is linked to functional impairment, joint restriction, and inflammation.
- Bone formation markers are reduced, while resorption markers are elevated, suggesting uncoupled bone remodeling.
Conclusions:
- Rheumatoid arthritis leads to significant bone loss and increased fracture risk due to imbalanced bone remodeling.
- Physical activity may mitigate bone loss.
- Estrogen therapy's role in RA is limited to menopause-related bone loss, and bisphosphonate efficacy is under investigation.